Delivery Order SPE2DB20D9202-SPE2DB23FK92X

Award Date 9/28/23
Potential Completion Date 10/20/23
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,881.40 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with an ultimate completion date of September 20, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award, valued at $4,288.14, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a performance period ending on September 26, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the...
This federal contract award, valued at $50,334.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with...
This federal contract award, valued at $11,325.24, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive implant product. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,576.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,002.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 68 mg NEXPLANON implants, a contraceptive medication, with a completion date of January 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
This federal contract award, valued at $94,377.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This federal contract award, valued at $15,100.32, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order (SPE2DB22FD2XT) for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award, valued at $1,852.17, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the procurement of NEXPLANON 68 MG IMPLANTS, a specialized contraceptive product, with a completion date of November 16, 2022. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $8,576.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG implants, a contraceptive product, with a performance period extending through April 5, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, which has a ceiling value of up to...
  • SPE2DB20D9202
    Indefinite Delivery Contract
  • SPE2DB20D9202-SPE2DB23FK92X
    Delivery Order

This contract award, valued at $34,254.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, to support the medical supply needs of military healthcare facilities.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare sites worldwide. The contract does not have a set-aside designation, which enables DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 11:56 AM